Admin Posted April 29, 2017 Share Posted April 29, 2017 If you live within spitting distance of Brisbane, the Prostate Cancer Foundation of Australia (PCFA) puts on a regular update event now called: Community Conversations Great facilitator and speakers. Great location: Translational Research Institute, where a team of about 50 staff try to find a cure to prostate cancer. (Near PA hospital.) Free lunch and refreshments Travel support may be available for Support Group Leaders who travel from beyond Brisbane A good chance to meet our Convenor, Jim Marshall (JimJimJimJim, silver mobility scooter) and other members of the Australian Advanced Prostate Cancer Support Group. The event is free, but you must register: Click here to book your place or call: 1800 22 00 99 or full details: http://www.prostate.org.au/get-involved/events/find-an-event/community-conversations/ When 10:00am - 3:30pm 19 May 2017 Where Translational Research Institute 37 Kent St Woolloongabba QLD 4102 This interactive forum will include • A straightforward overview of the current treatment options for patients • The latest developments from PCFA-funded research leading the way to improve management of prostate cancer • Diet and nutrition recommendations that may assist manage the side effects of treatment and the ongoing impact of prostate cancer • Simple ways to prepare nutritious and delicious meals • Q&A session with health professionals on managing the day-to-day challenges of living with prostate cancer • Personal stories shared by those who have experienced prostate cancer Community Conversations will also be presented in Mandarin via a professional interpreter. For further information about this service please click here. Facilitator Julie McCrossin talks to people for a living. After 20 years as a broadcaster with ABC Radio National, ABC TV and Network Ten, she is now a freelance journalist and facilitator. Speakers Professor Suzanne Chambers is the Director of the Menzies Health Institute, Queensland and a health psychologist with 20 years of experience in psychological support for people with cancer. She is a behavioural science researcher, specialising in the fields of psycho-oncology and cancer survivorship. Professor Jenny Doust is Professor of Clinical Epidemiology at Bond University. She is a trained GP, clinical epidemiologist and economist whose research interests have included PSA testing and diagnosis of prostate cancer. Associate Professor Anthony Lowe is the CEO at Prostate Cancer Foundation Australia. He has driven many successful initiatives such as resource development for prostate cancer support groups, survivorship research, and the development of PSA testing guidelines. Chris McNamara has been a Prostate Cancer Specialist Nurse at Greenslopes Private Hospital for two and a half years. He works with other members of multidisciplinary teams to provide excellence in care and a point of continuity through treatment, for prostate cancer patients and their families. Amy Parker is the Manager of Community Support Services at Cancer Council Queensland. She has extensive experience in providing information, support and service referrals for people with cancer. Dr Michele Teng is the Team Head of the Cancer Immunoregulation and Immunotherapy Laboratory at QIMR Berghofer Medical Research Institute in Queensland. Her research is aimed at developing novel immunotherapies to tackle diseases such as prostate cancer. Dr Ian Vela is a Urologic Oncologist at the Princess Alexandra Hospital in Brisbane and laboratory head at the Australian Prostate Cancer Research Centre. His research aims to develop a precision medicine program for men with advanced and metastatic prostate cancer Dr Olivia Wright is an Advanced Accredited Practising Dietitian and a lecturer in Nutrition and Dietetics at the University of Queensland. Her research into prostate cancer has focussed on preventing osteoporosis and reducing cancer-related fatigue in men with prostate cancer Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.